IDIM - Sede Centro - CABA

Instituto de Investigaciones Metabólicas
logoIDIM - Sede Centro - CABA
Libertad 836, C1012AAR Cdad. Autónoma de Buenos Aires, Argentina
Select an option

Our team

Authorities
Directora Médica / Investigadora PrincipalMaria Belen Zanchetta
Director de Investigación ClínicaMarcelo Belgrano
Director EjecutivoHernán Rebasa
Medical staff
Sub InvestigadorJuan Boailchuk
Sub InvestigadoraVerónica Laplacette
Sub InvestigadoraTania Rabinovich
Investigadora PrincipalMariela Bazán
Investigador PrincipalSantiago Bruzone
Investigador PrincipalRicardo Del Olmo
Investigadora PrincipalDolores Clifton
Investigadora PrincipalKarina Danilowicz
Investigadora PrincipalVeronica Figueroa
Investigadora PrincipalFátima Pagani
Sub InvestigadoraNoemí Alvarez
Investigadora PrincipalMara Rapaccioli
Investigador PrincipalMartín Paskevicius
Sub InvestigadoraCarina Monteverde
Legal and Administrative staff
CoordinadoraAlejandra Barzaghi
CoordinadoraGiselle Morales
CoordinadoraRita Cecilia Bellotti
Gerente de OperacionesFernando Silveira

Open studies

Fatty liver/nash
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - ENLIGHTEN-Fibrosis - 89bio, Inc.See more
Lung cancer
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) - KRYSTAL-4 - Mirati Therapeutics Inc.See more
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) - GlaxoSmithKlineSee more
Steatohepatitis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - ENLIGHTEN-Fibrosis - 89bio, Inc.See more
Chronic obstructive pulmonary disease
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - THARROS - AstraZenecaSee more
Cirrhosis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Migraine
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine - PfizerSee more
Multiple Sclerosis
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis - FREXALT - SanofiSee more
Renal disease
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease - Boehringer IngelheimSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy